How well GLP-1 weight loss drugs work may depend on your genetics
Scientific AmericanAPR 11
Study: Genes May Affect Weight Loss Drug Results
Is genetics the key to unlocking personalized weight loss treatment or is the science still too early to matter?
Image credit: Unsplash
The Spin
Narrative A
Genetics finally explains why Ozempic works wonders for some and barely budges the scale for others. This massive genome-wide study of nearly 28,000 people pinpointed a missense variant in GLP1R that boosts weight loss and identified variants tied to nausea — proof that DNA shapes drug response in biologically meaningful ways. Precision medicine for obesity isn't a distant dream; it's the next logical step.
Narrative B
Exciting genetics headlines shouldn't obscure a modest reality — the GLP1R variant linked to extra weight loss amounts to roughly 1.5 pounds against a median 25-pound total loss, explaining just 3.6% of additional variance. Drug choice, dose, sex and duration matter far more than any gene variant identified so far. Precision medicine for GLP-1s is genuinely coming, but today's genetic data simply isn't ready to guide real clinical decisions.
Metaculus Prediction
Articles on this story
© 2026 Improve the News Foundation. All rights reserved.Version 6.18.0
© 2026 Improve the News Foundation.
All rights reserved.
Version 6.18.0